MY148901A - Pyrrole derivatives as p2y12 antagonists - Google Patents
Pyrrole derivatives as p2y12 antagonistsInfo
- Publication number
- MY148901A MY148901A MYPI20094985A MYPI20094985A MY148901A MY 148901 A MY148901 A MY 148901A MY PI20094985 A MYPI20094985 A MY PI20094985A MY PI20094985 A MYPI20094985 A MY PI20094985A MY 148901 A MY148901 A MY 148901A
- Authority
- MY
- Malaysia
- Prior art keywords
- compounds
- adp receptor
- platelet adp
- formula
- antagonists
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000003233 pyrroles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002744 anti-aggregatory effect Effects 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
- 230000009424 thromboembolic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290755 | 2007-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY148901A true MY148901A (en) | 2013-06-14 |
Family
ID=39092503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20094985A MY148901A (en) | 2007-06-18 | 2008-06-04 | Pyrrole derivatives as p2y12 antagonists |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7910576B2 (https=) |
| EP (1) | EP2167487B1 (https=) |
| JP (1) | JP5371969B2 (https=) |
| KR (1) | KR20100020478A (https=) |
| CN (1) | CN101679358B (https=) |
| AU (1) | AU2008266515B2 (https=) |
| BR (1) | BRPI0812912A2 (https=) |
| CA (1) | CA2690243A1 (https=) |
| IL (1) | IL202758A (https=) |
| MX (1) | MX2009013431A (https=) |
| MY (1) | MY148901A (https=) |
| WO (1) | WO2008155022A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008051440A1 (en) | 2006-10-20 | 2008-05-02 | Novartis Ag | Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione |
| US9539246B2 (en) | 2011-08-30 | 2017-01-10 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| MX2021012105A (es) | 2019-04-03 | 2021-11-03 | Aligos Therapeutics Inc | Compuestos de pirrol. |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3458515A (en) * | 1966-07-21 | 1969-07-29 | American Home Prod | Piperazine substituted pyrroles |
| US20020061892A1 (en) * | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
| US6861424B2 (en) | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
| US6956040B2 (en) * | 2001-07-16 | 2005-10-18 | Ranbaxy Laboratories Limited | Oxazolidinone piperazinyl derivatives as potential antimicrobials |
| DE60333866D1 (de) | 2002-12-11 | 2010-09-30 | Bayer Schering Pharma Ag | 2-aminocarbonlyl-chinolin-verbindungen als adenosin diphosphat plättchenrezeptor antagonisten |
| WO2005009971A1 (ja) | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | キノロン誘導体又はその塩 |
| US7273881B2 (en) * | 2004-01-16 | 2007-09-25 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| CN1778801A (zh) * | 2004-11-22 | 2006-05-31 | 中国农业科学院兰州畜牧与兽药研究所 | 喹诺酮7－((4－((z)－2－(2－氨基－4－噻唑基)－2－甲氧亚胺乙酰基)－1－哌嗪基)化合物及其制备方法 |
| BRPI0606437A (pt) * | 2005-01-06 | 2008-03-11 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta |
| JP2008094720A (ja) | 2005-01-20 | 2008-04-24 | Astellas Pharma Inc | キノロン誘導体のプロドラッグ又はその塩 |
| WO2006103544A2 (en) * | 2005-03-28 | 2006-10-05 | Pharmacia & Upjohn Company Llc | 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| PT1951254E (pt) * | 2005-11-03 | 2012-04-12 | Portola Pharm Inc | [4-(6-halo-7-substituído-2,4-dioxo-1,4-di-hidro-2hquinazolin- 3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureias e formas e métodos relacionados com as mesmas |
| US20070259879A1 (en) * | 2006-03-06 | 2007-11-08 | Trimeris, Inc. | Piperazine and piperidine biaryl derivatives |
-
2008
- 2008-06-04 AU AU2008266515A patent/AU2008266515B2/en not_active Ceased
- 2008-06-04 MY MYPI20094985A patent/MY148901A/en unknown
- 2008-06-04 WO PCT/EP2008/004459 patent/WO2008155022A1/en not_active Ceased
- 2008-06-04 BR BRPI0812912-6A2A patent/BRPI0812912A2/pt not_active IP Right Cessation
- 2008-06-04 KR KR1020097026371A patent/KR20100020478A/ko not_active Ceased
- 2008-06-04 EP EP08759015.4A patent/EP2167487B1/en not_active Withdrawn - After Issue
- 2008-06-04 CA CA2690243A patent/CA2690243A1/en not_active Abandoned
- 2008-06-04 MX MX2009013431A patent/MX2009013431A/es active IP Right Grant
- 2008-06-04 CN CN2008800208356A patent/CN101679358B/zh not_active Expired - Fee Related
- 2008-06-04 JP JP2010512555A patent/JP5371969B2/ja not_active Expired - Fee Related
-
2009
- 2009-12-15 IL IL202758A patent/IL202758A/en not_active IP Right Cessation
- 2009-12-16 US US12/639,500 patent/US7910576B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100020478A (ko) | 2010-02-22 |
| HK1142593A1 (en) | 2010-12-10 |
| IL202758A0 (en) | 2010-06-30 |
| IL202758A (en) | 2013-09-30 |
| CA2690243A1 (en) | 2008-12-24 |
| WO2008155022A1 (en) | 2008-12-24 |
| EP2167487A1 (en) | 2010-03-31 |
| EP2167487B1 (en) | 2015-02-18 |
| CN101679358A (zh) | 2010-03-24 |
| JP2010530380A (ja) | 2010-09-09 |
| MX2009013431A (es) | 2010-01-15 |
| US20100226918A1 (en) | 2010-09-09 |
| AU2008266515B2 (en) | 2014-05-01 |
| US7910576B2 (en) | 2011-03-22 |
| AU2008266515A1 (en) | 2008-12-24 |
| CN101679358B (zh) | 2013-10-30 |
| JP5371969B2 (ja) | 2013-12-18 |
| BRPI0812912A2 (pt) | 2014-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009011089A (es) | Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12. | |
| WO2009080226A3 (en) | Heterocyclic pyrazole-carboxamides as p2y12 antagonists | |
| WO2009080227A3 (en) | Pyrazole-carboxamide derivatives as p2y12 antagonists | |
| WO2009010871A3 (en) | Pyrazole derivatives as antagonists of adenosine a3 receptor | |
| NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
| WO2009010454A3 (en) | Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors | |
| SG10201906942PA (en) | Piperidine cxcr7 receptor modulators | |
| GEP20156285B (en) | Compounds and compositions as trk inhibitors | |
| WO2008132139A3 (en) | New heterocyclic derivatives useful for the treatment of cns disorders | |
| WO2006032342A3 (de) | Arzneimittel enthaltend carbonylverbindungen sowie deren verwendung | |
| NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
| TW200833326A (en) | Chemical compounds 572 | |
| IL189191A0 (en) | Thiazolyl piperidine derivatives useful as h3 receptor modulators | |
| WO2012047017A3 (ko) | 2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물 | |
| WO2008080844A9 (en) | Azaspiro derivatives | |
| MY147588A (en) | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives | |
| WO2010007316A3 (fr) | NOUVEAUX DERIVES TRIAZOLO(4,3-a)PYRIDINE,LEUR PROCEDE DE PREPARATION,LEUR APPLICATION A TITRE DE MEDICAMENTS,COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET | |
| MY143581A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
| TW200612936A (en) | Indole derivatives | |
| MX2009010505A (es) | Derivados de piridina y pirimidina como antagonistas de mglur2. | |
| WO2009013348A3 (en) | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions | |
| PH12012501863A1 (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
| IL202758A (en) | Pyrol derivatives as p2y12 antagonists | |
| MX2008016358A (es) | Derivados de tiazolil-urea como inhibidores de cinasa de fosfatidil-inositol-3. | |
| WO2008077810A3 (en) | Spiro-piperidine derivatives |